XW033MA ICD-10-PCS Code: Introduction of Emapalumab-lzsg Anti-IFNy Monoclonal Antibody into Peripheral Vein, Percutaneous Approach, New Technology Group 10

Related Codes

Same operation — other Body Part

Same table and root operation, differing only in the body part character.

XW043MA — Introduction of Emapalumab-lzsg Anti-IFNy Monoclonal Antibody into Central Vein, Percutaneous Approach, New Technology Group 10

Same operation — other Device / Substance / Technology

Same table and root operation, differing only in the device / substance / technology character.

XW0335A — Introduction of Ceftobiprole Medocaril Anti-infective into Peripheral Vein, Percutaneous Approach, New Technology Group 10, XW0338A — Introduction of Obecabtagene Autoleucel into Peripheral Vein, Percutaneous Approach, New Technology Group 10, XW0339A — Introduction of Odronextamab Antineoplastic into Peripheral Vein, Percutaneous Approach, New Technology Group 10, XW033BA — Introduction of Orca-T Allogeneic T-cell Immunotherapy into Peripheral Vein, Percutaneous Approach, New Technology Group 10, XW033CA — Introduction of Zanidatamab Antineoplastic into Peripheral Vein, Percutaneous Approach, New Technology Group 10, XW033DA — Introduction of Donislecel-jujn Allogeneic Pancreatic Islet Cellular Suspension into Peripheral Vein, Percutaneous Approach, New Technology Group 10, XW033FA — Introduction of Non-Chimeric Antigen Receptor T-cell Immune Effector Cell Therapy into Peripheral Vein, Percutaneous Approach, New Technology Group 10, XW033NA — Introduction of Tarlatamab-dlle Antineoplastic into Peripheral Vein, Percutaneous Approach, New Technology Group 10, +2 more

Same operation — other Qualifier

Same table and root operation, differing only in the qualifier character.

XW033M7 — Introduction of Brexucabtagene Autoleucel Immunotherapy into Peripheral Vein, Percutaneous Approach, New Technology Group 7

Same procedure category (CCSR), other tables

AHRQ's Clinical Classifications Software Refined groups these ICD-10-PCS procedures with this one under Administration of therapeutic substances, NEC (Administration of Therapeutic Substances); listed here are the members in other PCS tables. Source: Clinical Classifications Software Refined (CCSR), Healthcare Cost and Utilization Project (HCUP), Agency for Healthcare Research and Quality, November 2025.

3E0U3TZ — Introduction of Destructive Agent into Joints, Percutaneous Approach, 3E0U4GC — Introduction of Other Therapeutic Substance into Joints, Percutaneous Endoscopic Approach, 3E0V0GB — Introduction of Recombinant Bone Morphogenetic Protein into Bones, Open Approach, 3E0V0GC — Introduction of Other Therapeutic Substance into Bones, Open Approach, 3E0V3GB — Introduction of Recombinant Bone Morphogenetic Protein into Bones, Percutaneous Approach, 3E0V3GC — Introduction of Other Therapeutic Substance into Bones, Percutaneous Approach, 3E0V3TZ — Introduction of Destructive Agent into Bones, Percutaneous Approach, 3E0V4GC — Introduction of Other Therapeutic Substance into Bones, Percutaneous Endoscopic Approach, 3E0W3GC — Introduction of Other Therapeutic Substance into Lymphatics, Percutaneous Approach, 3E0W3TZ — Introduction of Destructive Agent into Lymphatics, Percutaneous Approach, 3E0X3GC — Introduction of Other Therapeutic Substance into Cranial Nerves, Percutaneous Approach, 3E0X3TZ — Introduction of Destructive Agent into Cranial Nerves, Percutaneous Approach, 3E0Y3GC — Introduction of Other Therapeutic Substance into Pericardial Cavity, Percutaneous Approach, 3E0Y3SF — Introduction of Other Gas into Pericardial Cavity, Percutaneous Approach, 3E0Y3TZ — Introduction of Destructive Agent into Pericardial Cavity, Percutaneous Approach, 3E0Y4GC — Introduction of Other Therapeutic Substance into Pericardial Cavity, Percutaneous Endoscopic Approach, 3E0Y7SF — Introduction of Other Gas into Pericardial Cavity, Via Natural or Artificial Opening, XY0VX83 — Extracorporeal Introduction of Endothelial Damage Inhibitor to Vein Graft, New Technology Group 3, XY0YX28 — Extracorporeal Introduction of Taurolidine Anti-infective and Heparin Anticoagulant, New Technology Group 8, XY0YX37 — Extracorporeal Introduction of Nafamostat Anticoagulant, New Technology Group 7, +213 more

Contextual Map

Every relationship of XW033MA in one view: hierarchy, official tabular instructions in both directions, clinical classification, risk adjustment, MS-DRG participation, index terms and change history — each edge carrying the CMS source it derives from.

PCS table

• XW0[PCS table]— CMS ICD-10-PCS tables
• New Technology — Section: New Technology[Section]: “New Technology”— CMS ICD-10-PCS tables
• Anatomical Regions — Body System: Anatomical Regions[Body System]: “Anatomical Regions”— CMS ICD-10-PCS tables
• Introduction — Operation: Introduction[Operation]: “Introduction”— CMS ICD-10-PCS tables

Clinical classification (CCSR)

• ADM021 — Administration of therapeutic substances, NEC[CCSR category]: “Administration of therapeutic substances, NEC — Administration of Therapeutic Substances”— AHRQ CCSR for ICD-10-PCS Procedures (HCUP) · v2026.1

Nearest codes

• XW0333A — Introduction of Bentracimab, Ticagrelor Reversal Agent into Peripheral Vein, Percutaneous Approach, New Technology Group 10[One axis away]— CMS ICD-10-PCS tables
• XW0334A — Introduction of Cefepime-taniborbactam Anti-infective into Peripheral Vein, Percutaneous Approach, New Technology Group 10[One axis away]— CMS ICD-10-PCS tables
• XW0335A — Introduction of Ceftobiprole Medocaril Anti-infective into Peripheral Vein, Percutaneous Approach, New Technology Group 10[One axis away]— CMS ICD-10-PCS tables
• XW0338A — Introduction of Obecabtagene Autoleucel into Peripheral Vein, Percutaneous Approach, New Technology Group 10[One axis away]— CMS ICD-10-PCS tables
• XW0339A — Introduction of Odronextamab Antineoplastic into Peripheral Vein, Percutaneous Approach, New Technology Group 10[One axis away]— CMS ICD-10-PCS tables
• XW033BA — Introduction of Orca-T Allogeneic T-cell Immunotherapy into Peripheral Vein, Percutaneous Approach, New Technology Group 10[One axis away]— CMS ICD-10-PCS tables
• XW033CA — Introduction of Zanidatamab Antineoplastic into Peripheral Vein, Percutaneous Approach, New Technology Group 10[One axis away]— CMS ICD-10-PCS tables
• XW033DA — Introduction of Donislecel-jujn Allogeneic Pancreatic Islet Cellular Suspension into Peripheral Vein, Percutaneous Approach, New Technology Group 10[One axis away]— CMS ICD-10-PCS tables

Change history

• FY2025 (April) — Added to the code set[Change history]— CMS release files (code change ledger) · icd10pcs-fy2025apr